Suchergebnisse - "Ibragimova, Khava I E"

PubPharm (15)

1

Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer : an analysis of the SONABRE registry

enthalten in: Breast cancer research and treatment | 2024

von Geurts, S. | Ibragimova, K. | Ding, N. | +16

2

Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer : Results From the SONABRE Registry

enthalten in: Clinical breast cancer | 2024

von Ibragimova, K. | Geurts, S. | Laczkó, D. | +14

3

Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer : results from the SONABRE registry

enthalten in: Breast cancer research and treatment | 2023

von Ibragimova, K. | Geurts, S. | Meegdes, M. | +12

4

Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry

enthalten in: Breast cancer research and treatment | 2023

von Ibragimova, K. | Geurts, S. | Meegdes, M. | +12

5

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer : a study of the SONABRE registry

enthalten in: Breast cancer research and treatment | 2022

von Meegdes, M. | Ibragimova, K. | Lobbezoo, D. | +16

6

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry

enthalten in: Breast cancer research and treatment | 2022

von Meegdes, M. | Ibragimova, K. | Lobbezoo, D. | +16

7

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry

enthalten in: Breast cancer research and treatment | 2022

von Meegdes, M. | Ibragimova, K. | Lobbezoo, D. | +16

8

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry

enthalten in: Breast cancer research and treatment | 2022

von Meegdes, M. | Ibragimova, K. | Lobbezoo, D. | +16

9

Healthcare Use during the Last Six Months of Life in Patients with Advanced Breast Cancer

enthalten in: Cancers | 2021

von Schmitz, R. | Geurts, S. | Ibragimova, K. | +3

10

Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry

enthalten in: Breast cancer research and treatment | 2021

von Ibragimova, K. | Geurts, S. | Croes, S. | +13